[Etiopathogenetic, clinical and therapeutic aspects of involutive myelopathies].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D045930:Anabolic Agents / Q000627:therapeutic use; D000741:Anemia, Aplastic / Q000150:complications / Q000188:drug therapy / Q000209:etiology; D001855:Bone Marrow Diseases; D002701:Chloramphenicol / Q000009:adverse effects; D004905:Erythrocyte Aging; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006457:Hemoglobinuria, Paroxysmal / Q000150:complications; D006801:Humans; D007501:Iron / Q000097:blood; D007938:Leukemia / Q000209:etiology; D008297:Male; D008875:Middle Aged; D011720:Pyrazoles / Q000009:adverse effects; D000637:Transaminases / Q000097:blood; D005719:gamma-Globulins / Q000032:analysis
D045930:Anabolic Agents; D005938:Glucocorticoids; D011720:Pyrazoles; D005719:gamma-Globulins; D002701:Chloramphenicol; D007501:Iron; D000637:Transaminases; D000469:Alkaline Phosphatase
Aspetti eziopathogenetici, clinici e terapeutici delle mielopatie involutive.